• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

IU Kelley School of Business at IUPUIGo from Moment to Momentum

AMA Offers Misdiagnosis with Pharma Advertising Ban

Posted on December 29, 2015 by Teresa Mackin

This story is adapted from an article written by Professor Anthony Cox, PhD for the Indianapolis Business Journal.

The American Medical Association (AMA) recently called for a total ban on direct-to-consumer (DTC) pharmaceutical advertising, saying the industry’s well-funded campaigns sway patients towards newer and more expensive drugs and away from older but affordable and effective treatments like generics.

The AMA argues that a barrage of commercials leads consumers to demand the latest drugs, straining doctor-patient relationships and fueling rising healthcare costs. Reports from the organization’s meeting in Atlanta (where the new policy was approved) highlighted comments by some physicians that advertising “interfered” with their ability to offer advice to patients fixated on brand names and lofty promises.

Anecdotes can be persuasive, but our research leads us to a qualified defense of DTC pharmaceutical advertising. While DTC ads can be annoying, we find that pharma ads are actually among the most honest forms of consumer advertising, that they can promote a more informed and open discussion between doctors and patients, and that they aren’t a major driver of higher prices.

Drug advertising is the most-regulated form of consumer advertising, governed by strict guidelines and oversight from the FDA. Anyone who has seen one of these ads recently – and who hasn’t? – knows that the various disclosures and disclaimers often take up most of the time allotted and can include graphic descriptions of potential side effects.

Because the FDA also regulates the approval of all new drugs, pharma companies have a strong incentive to live within the guidelines and maintain good relations with the agency – a motivation that other consumer advertisers lack with the Federal Trade Commission.

Since these ads are clearly identified as promotional messages, they also warn consumers to be skeptical of their claims. Today, we have more ways to avoid ads altogether or aggressively investigate the pros and cons through online access to a vast library of medical resources, expert opinion and real patient stories.

So while DTC advertising may make a certain drug top-of-mind, it also leads wary consumers to come to their physicians armed with research, follow-up questions and concerns. Our natural instinct to think critically about advertising may lead to a more thorough conversation –a dialogue that doctors should welcome.

Even the brand awareness impact may be overstated: A recent survey of physicians (Parnes et al) finds that patients mention specific drug names in less than 5% of doctor visits – hardly a testament to the efficiency of paid advertising.

It’s also important to note that over 80% of pharma marketing budgets are still focused on promotions to physicians themselves, including advertising in medical journals, visits from sales reps, distributing samples of new drugs, even payments to physicians. All of these activities influence physicians to prescribe newer, more expensive drugs; most important, they are largely hidden from patients. In contrast, direct-to-consumer advertising is the much more transparent form of persuasion.

Just as DTC advertising is one element of a broader communications effort, it represents just a tiny sliver of overall prescription drug costs. Rising drug prices are a very real concern, but advertising expenses are far too small compared to total spending to be singled out as a major culprit.

The AMA may be well-meaning in its call for an advertising ban, but we’d encourage them to apply the same level of outrage to the meals, junkets and free samples showered on doctors by drugmakers.

If the AMA truly wants to reduce the undue influence of pharmaceutical marketing, perhaps the first prescription should be “physician, heal thyself.”

Tony Cox is a Professor of Marketing at the IU Kelley School of Business in Indianapolis; he focuses on healthcare consumer decisions and chairs Kelley’s Business of Medicine Physician MBA program.

 

Filed under: Healthcare, Physician MBA Program

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

About the Kelley School at IUPUI

The Kelley School of Business at IUPUI is home to a full-time undergraduate program and five graduate programs, including a graduate certificate for professionals in healthcare; master’s and graduate certificate programs in accounting, internal audit and taxation; the Physician MBA and the Evening MBA, which is ranked eleventh in the country by U.S. News & World Report.

Categories

Search Posts

Receive Updates

Get the latest news from the Kelley School's Indianapolis programs, faculty, students and alumni delivered directly to your Inbox

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent Posts

  • Physician MBA authors book about physician burnout and coaches other MDs on their careers March 9, 2023
  • International student from Spain finds home and future at Kelley Indianapolis March 7, 2023
  • Global HR leader credits his Kelley network for paving the way for his professional success February 23, 2023
  • Former public and tribal attorney uses Evening MBA in move into business law February 15, 2023
  • Kelley School of Business to lead global physician trip to London, Paris February 13, 2023

See Archived Posts

Kelley School Faculty at IUPUI

Full list of faculty based in Indianapolis.

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.